JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sagawa, K.
Right arrow Articles by Morris, M. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sagawa, K.
Right arrow Articles by Morris, M. E.

Vol. 294, Issue 2, 658-663, August 2000

Glucocorticoid-Induced Alterations of Renal Sulfate Transport1

Kazuko Sagawa2 , Inger M. Darling, Heini Murer and Marilyn E. Morris

Department of Pharmaceutics (K.S., I.M.D., M.E.M.), State University of New York at Buffalo, Amherst, New York; and Institute of Physiology (H.M.), University of Zürich, Zürich, Switzerland

Glucocorticoid administration decreases renal sodium/phosphate cotransport in the proximal tubule due to a down-regulation of the sodium/phosphate cotransporter but has no effect on the sodium-dependent transport of glucose or proline. The objectives of the present investigation were to determine the effects of the glucocorticoid methylprednisolone (MPL) on 1) inorganic sulfate renal clearance in rats in vivo, 2) sodium/sulfate cotransport in kidney cortex membrane vesicles, and 3) the cellular mechanism of the MPL-induced alterations in sulfate renal transport. Male adrenalectomized Wistar rats received an i.v. dose of 50 mg/kg MPL or the vehicle. Urine samples were collected for 12 h after the administration of MPL, and blood samples were collected at the midpoint of the urine collection. Other animals were sacrificed at 4, 6, and 12 h after MPL administration, and the kidney cortex was removed for RNA or membrane preparations. Kidney cortex sodium/sulfate cotransporter (NaSi-1) mRNA levels were determined by reverse transcription-polymerase chain reaction and NaSi-1 protein levels were determined by enzyme-linked immunosorbent assay. The urinary excretion rate and renal clearance of sulfate were significantly increased in MPL-treated animals (144.0 ± 27.0 versus 65.3 ± 21.3 µmol/12 h/kg and 0.208 ± 0.038 versus 0.078 ± 0.025 ml/min/kg, mean ± S.E., n = 9-12 in treated versus control). The Vmax value for sodium-dependent sulfate transport in brush border membrane vesicles (representing reabsorption in the proximal tubules) was significantly decreased in MPL-treated animals compared with controls (0.68 ± 0.07 versus 0.88 ± 0.05 nmol/mg of protein/10 s, mean ± S.E.). There was no change in the Km value for sodium/sulfate cotransport in brush-border membrane and no change in sulfate/anion exchange in basolateral membrane vesicles. Membrane fluidity in brush border membrane and basolateral membrane vesicles, determined by the fluorescence polarization of 1,6-diphenyl-1,3,5-hexatriene was unaltered by MPL treatment. NaSi-1 mRNA levels were significantly decreased at 4 and 6 h, but not 12 h, after MPL administration, whereas NaSi-1 protein expression was significantly decreased at 4, 6, and 12 h. Therefore, MPL treatment increases the renal clearance of inorganic sulfate, at least in part, due to down-regulation of NaSi-1 mRNA and protein expression in the kidney.


1 This work was supported by a POWRE grant from the National Science Foundation (IBN 9973499) and grants from the Western New York Kidney Foundation/Upstate NY Transplant Services. The work was presented as an abstract at the American Association of Pharmaceutical Scientists Annual Meeting, November 1999.

2 Present address: Central Research Division, Pfizer Inc., Groton, CT 06340.


0022-3565/00/2942-0658$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 2000 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
T. Nakada, K. Zandi-Nejad, Y. Kurita, H. Kudo, V. Broumand, C. Y. Kwon, A. Mercado, D. B. Mount, and S. Hirose
Roles of Slc13a1 and Slc26a1 sulfate transporters of eel kidney in sulfate homeostasis and osmoregulation in freshwater
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2005; 289(2): R575 - R585.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
R. M. Pelis and J. L. Renfro
Role of tubular secretion and carbonic anhydrase in vertebrate renal sulfate excretion
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2004; 287(3): R491 - R501.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
R. M. Pelis, J. E. Goldmeyer, J. Crivello, and J. L. Renfro
Cortisol alters carbonic anhydrase-mediated renal sulfate secretion
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2003; 285(6): R1430 - R1438.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
P. L. Dudas and J. L. Renfro
Transepithelial sulfate transport by avian renal proximal tubule epithelium in primary culture
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2002; 283(6): R1354 - R1361.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
D. Markovich
Physiological Roles and Regulation of Mammalian Sulfate Transporters
Physiol Rev, October 1, 2001; 81(4): 1499 - 1533.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2000 by the American Society for Pharmacology and Experimental Therapeutics.